Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2016, Article ID 1628932, 4 pages
http://dx.doi.org/10.1155/2016/1628932
Case Report

Treatment of Polymicrobial Osteomyelitis with Ceftolozane-Tazobactam: Case Report and Sensitivity Testing of Isolates

1Kern Medical, 1700 Mount Vernon Avenue, Bakersfield, CA 93306-4018, USA
2University of the Pacific School of Pharmacy & Health Sciences, 3601 Pacific Avenue, Stockton, CA 95211-0109, USA

Received 21 March 2016; Accepted 6 June 2016

Academic Editor: Arlene C. Sena

Copyright © 2016 Jeffrey C. Jolliff et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y.-T. Chang, C.-Y. Lin, Y.-H. Chen, and P.-R. Hsueh, “Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options,” Frontiers in Microbiology, vol. 6, article 893, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. M. E. Falagas, P.-E. Valkimadi, Y.-T. Huang, D. K. Matthaiou, and P.-R. Hsueh, “Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review,” Journal of Antimicrobial Chemotherapy, vol. 62, no. 5, pp. 889–894, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. D. J. Farrell, H. S. Sader, and R. N. Jones, “Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 6, pp. 2735–2737, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. H. S. Sader, R. K. Flamm, and R. N. Jones, “Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011),” Diagnostic Microbiology and Infectious Disease, vol. 76, no. 2, pp. 217–221, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. J. C. Cho, M. A. Fiorenza, and S. J. Estrada, “Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination,” Pharmacotherapy, vol. 35, no. 7, pp. 701–715, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Cluck, P. Lewis, B. Stayer, J. Spivey, and J. Moorman, “Ceftolozane-tazobactam: a new-generation cephalosporin,” American Journal of Health-System Pharmacy, vol. 72, no. 24, pp. 2135–2146, 2015. View at Publisher · View at Google Scholar
  7. R. Soliman, S. Lynch, E. Meader et al., “Successful ceftolozane/tazobactam treatment of chronic pulmonary infection with panresistant Pseudomonas aeruginosa,” JMM Case Reports, 2015. View at Publisher · View at Google Scholar
  8. A. Alqaid, C. K. Dougherty, and S. Ahmad, “Triple antibiotic therapy with ceftolozane/tazobactam, colistin and rifampin for pan-resistant Pseudomonas aeruginosa ventilator-associated pneumonia,” SWRCCC, vol. 3, no. 11, pp. 35–39, 2015. View at Publisher · View at Google Scholar
  9. J. E. Garcia Sanchez, M. L. Vazquez Lopez, A. M. Blazquez De Castro et al., “Aztreonam/clavulanic acid in the treatment of serious infections caused by Stenotrophomonas maltophilia in neutropenic patients: case reports,” Journal of Chemotherapy, vol. 9, no. 3, pp. 238–240, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Leung, P. Drew, and E. A. Azzopardi, “Extended multidrug-resistant Stenotrophomonas maltophilia septicemia in a severely burnt patient,” Journal of Burn Care and Research, vol. 31, no. 6, p. 966, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. P. N. Pérez, M. A. Ramírez, J. A. Fernández, and L. L. de Guevara, “A patient presenting with cholangitis due to Stenotrophomonas maltophilia and Pseudomonas aeruginosa successfully treated with intrabiliary colistine,” Infectious Disease Reports, vol. 6, no. 2, pp. 17–19, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. C. B. Landersdorfer, J. B. Bulitta, M. Kinzig, U. Holzgrabe, and F. Sörgel, “Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations,” Clinical Pharmacokinetics, vol. 48, no. 2, pp. 89–124, 2009. View at Publisher · View at Google Scholar · View at Scopus